Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the overall survival of patients with stage
IV pancreatic cancer treated with gemcitabine alone or gemcitabine with bavituximab.